Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Treatment of Alzheimer's disease.

Mayeux R, Sano M.

N Engl J Med. 1999 Nov 25;341(22):1670-9. Review. No abstract available.

PMID:
10572156
2.

Pharmaceutical treatment of cognitive disorders in Alzheimer's disease.

Senin U, Cherubini A, Palumbo B, Mecocci P.

Funct Neurol. 1997 May-Aug;12(3-4):211-2. No abstract available.

PMID:
9218980
3.

[Drug therapy strategies in Alzheimer's disease].

Lacomblez L.

Rev Prat. 1998 Nov 1;48(17):1913-7. French.

PMID:
9854394
4.

Alzheimer's disease: clinical evaluation and disease management--update.

Richter RW.

J Okla State Med Assoc. 2004 Dec;97(12):546-54; quiz 555-6. Review. No abstract available.

PMID:
15732886
5.
6.

Drug treatment for Alzheimer's disease.

Tom T, Cummings JL.

West J Med. 1998 Apr;168(4):264. No abstract available.

7.

Advances in the treatment of Alzheimer's disease.

Schneider LS.

Aging (Milano). 1998 Apr;10(2):156-7. No abstract available.

PMID:
9666210
8.

Drug treatment of Alzheimer's disease and responders to rivastigmine beyond 12 weeks.

McMillan H.

Int J Geriatr Psychiatry. 1999 Dec;14(12):1078-9. No abstract available.

PMID:
10607978
9.

Rivastigmine for Alzheimer's disease.

[No authors listed]

Drug Ther Bull. 2000 Feb;38(2):15-6. Review.

PMID:
10829350
10.

Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine.

Linkins KW, Lloyd JR, Hjelmstad GO, Strausbaugh HJ.

Pharmacoeconomics. 2000 Dec;18(6):609-12. No abstract available.

PMID:
11227398
11.

Rivastigmine (Exelon) for Alzheimer's disease.

[No authors listed]

Med Lett Drugs Ther. 2000 Oct 2;42(1089):93-4. No abstract available.

PMID:
11015159
12.

[Strategies for the treatment of Alzheimer's disease. The 'ad continuum' concept].

Boada Rovira M.

Rev Neurol. 2001 Jun 1-15;32(11):1074-84. Review. Spanish.

PMID:
11562834
13.

[Alzheimer's disease. Foreword].

Derquesné C.

Rev Prat. 1998 Nov 1;48(17):1871-2. French. No abstract available.

PMID:
9882238
14.

Empirical evidence of neuroprotection by dual cholinesterase inhibition in Alzheimer's disease.

Venneri A, McGeown WJ, Shanks MF.

Neuroreport. 2005 Feb 8;16(2):107-10.

PMID:
15671856
15.
16.

[The treatment of Alzheimer's disease].

Ankri J.

Rev Neurol (Paris). 2003 Sep;159(8-9):819-24. Review. French. No abstract available.

PMID:
13679729
17.

Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly.

VanDenBerg CM, Kazmi Y, Jann MW.

Drugs Aging. 2000 Feb;16(2):123-38. Review.

PMID:
10755328
18.

[New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].

Frölich L, Schmitt B, Calabrese P, Diener H, Förstl H, Gertz HJ, Hallauer JF, Hampel H, Ihl R, Rieke K, Riepe M, Supprian T.

Dtsch Med Wochenschr. 2005 Feb 25;130(8):408-12. Review. German. No abstract available.

PMID:
15717252
19.

Searching for drugs that combat Alzheimer's.

Marx J.

Science. 1996 Jul 5;273(5271):50-3. No abstract available.

PMID:
8658194
20.

Supplemental Content

Support Center